Data / Form D filings / ChromaCode, Inc.
ChromaCode, Inc.: Form D filings
ChromaCode, Inc., a biotechnology company in Carlsbad, CA, filed 7 Form D notices with the SEC between 2017 and 2025. The latest, on February 5, 2025, reports $3.8 million sold of a $5 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2292 FARADAY AVENUE, SUITE 110, Carlsbad, CA, 92008
- Phone
- (442) 244-4370
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1704675
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | New notice | $4,999,997 | $3,849,998 | $1,149,999 | 4 | Jan 30, 2025 | sec.gov |
| Feb 27, 2023 | Amendment | $42,967,511 | $37,967,513 | $4,999,998 | 16 | Feb 28, 2022 | sec.gov |
| Mar 3, 2022 | New notice | $50,685,025 | $27,967,512 | $22,717,513 | 15 | Feb 28, 2022 | sec.gov |
| Dec 3, 2020 | Amendment | $41,248,842 | $38,643,880 | $2,604,962 | 17 | Aug 9, 2019 | sec.gov |
| Aug 16, 2019 | New notice | $37,792,492 | $26,093,882 | $11,698,610 | 11 | Aug 9, 2019 | sec.gov |
| Apr 16, 2019 | New notice | $3,500,000 | $1,750,000 | $1,750,000 | 6 | Apr 4, 2019 | sec.gov |
| Apr 25, 2017 | New notice | $12,136,023 | $12,024,997 | $111,026 | 9 | Apr 17, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Aditya Rajagopal | Director | |
| Paul Flook | Executive Officer, Director | |
| Justin Klein | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Feb 3, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ChromaCode, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.